x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

science life sciences

All Episodes

43:07

The Spanish solid state specialist

Molecule to Market: Inside the outsourcing space ·

2025/05/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Victor Diaz, Co-Founder of Solitek.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Victor, covering: Falling in love with medicinal chemistry and ending up experiencing the culture shock of North East England! Why Victor fell in love with working on a variety of projects at CROs/CDMOs The benefits of solid state chemistry and its value

en

50:39

The bullish CDMO CEO making bold moves

Molecule to Market: Inside the outsourcing space ·

2025/05/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeremie Trochu, CEO at Ardena.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeremie, covering: The value of hitting the road and getting in front of clients, helping build several career-critical skills The big decision to leave med-tech giant GE and move to an ambitious, growing CDMO called...Catalent How the stars aligned to move

en

56:40

Geordie lad done good in pharma

Molecule to Market: Inside the outsourcing space ·

2025/05/02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Rob Wood, pharma portfolio investor and Founder.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Rob, covering: Identifying a niche in the pharma services space that led to working with top 50 Big Pharma Growing STEM into an international powerhouse before eventually selling to UDG Healthcare Life as a pharma portfolio advisor and

en

48:58

The CEO driven by lentiviral vector success

Molecule to Market: Inside the outsourcing space ·

2025/04/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jon Alberdi, CEO at VIVEbiotech.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jon, covering: Falling in love with the world of management and its role in influencing people and society Why, after 12 years in the B2B automotive sector, did he decide to jump into the life science space? His first impressions of the sector and the viral

en

50:28

The CRDMO CEO making his luck

Molecule to Market: Inside the outsourcing space ·

2025/04/18

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Philip Lee, CEO at GeneFab.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Philip, covering: The role of luck in the development of his entrepreneurial journey of multiple biopharma start-ups Bootstrapping a biological tech company and then selling to Millipore, along with lessons learnt from a more prominent global organization Building

en

52:59

The biotech CEO focused on curing paediatric deafness

Molecule to Market: Inside the outsourcing space ·

2025/04/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jodi Cook PhD, President and CEO at Skylark Bio.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jodi, covering: How a curiosity for unanswered questions led her to a PhD and a career in biotech… and, ultimately, the magical, rare experience of getting a product to market The full-circle moment that took Jodi from being an audiologist to

en

52:46

Inside the mind of the CDMO customer

Molecule to Market: Inside the outsourcing space ·

2025/04/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Julien Laizé, Director External Manufacturing CTM at Valneva.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Julien, covering: Comparative views of being externally outsourced in large pharma's R&D vs a more action-oriented, small-med pharma company Taking us behind the scenes into in-housing vs outsourcing manufacturing decisions

en

48:52

The master-builder now on a cell therapy crusade

Molecule to Market: Inside the outsourcing space ·

2025/03/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason C. Foster, Chief Executive Officer and Executive Director at Ori Biotech.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering: How being frustrated by big company life led to the development of a business unit within Reckitt Benckiser that went on to be valued at $1bn The story of how a spin-out went on to list on the

en

54:53

From astrophysicist to biopharma industry leader

Molecule to Market: Inside the outsourcing space ·

2025/03/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ben Locwin, Chief Scientist, Head of Clinical Services and Project Sciences at Black Diamond Networks (BDN).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ben, covering: Being part of the Lonza growth story in its 'scrappy' years Learning never to say no to a good opportunity and how that's opened many doors Becoming part of the more

en

52:32

From Big Pharma to Snapdragon

Molecule to Market: Inside the outsourcing space ·

2025/03/14

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matthew Bio, CSO, Cambrex & President, Snapdragon ChemistryYour host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: The frustrating experience of not having ownership or being hands-on at big pharma middle management Recounting the early days of Snapdragon Chemistry and being in the right place at the right time to harness

en

47:24

The LATAM CRO Queen

Molecule to Market: Inside the outsourcing space ·

2025/03/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Tylosky, CEO at Farmacon Global.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sara, covering: The gift and curse of being known for rescuing complex clinical trials The data challenge of rare diseases and how that impacts patient access Navigating the complexity of rare diseases in Latin America and why it all starts with

en

56:00

The pulse of Big Pharma CEOs

Molecule to Market: Inside the outsourcing space ·

2025/02/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ray Pressburger, Senior Managing Director, Accenture Strategy - Lead for Life Sciences and US Market Products Industries.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ray, covering: Continuously making mistakes as an authentic leader, and his journey across two decades at Accenture The five most important themes for CEOs of the 10 big

en

41:34

How to plan for life sciences events in 2025

Molecule to Market: Inside the outsourcing space ·

2025/02/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Luke Bilton, Co-Founder at Life Science Networks, PharmaSource and CDMO Live.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Luke, covering: How Covid exposed the complacency of event organizers in pharma services Behind the scenes of organizing CPHI Worldwide - what's it really like - chaos or calm? How companies should be thinking

en

55:43

Biopharma Global Supply veteran

Molecule to Market: Inside the outsourcing space ·

2025/02/14

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Robert Bottome, a global supply veteran.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Robert, covering: Stretching yourself by tapping into the collective wisdom of others The challenge of pairing internal production capacity with the need for agile, rapid early phase R&D The decision to leave Genentech to do a 'do over' and do

en

52:48

Meet the healthcare futurist

Molecule to Market: Inside the outsourcing space ·

2025/02/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Imran Kausar, Founder of DeepHealth Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Imran, covering: His unusual blend of experience led to a road into big pharma... Switching the security of Big Pharma to join an exciting, scrappy, start-up biotech... before an exit to Roche Being part of the gene therapies evolution with an

en

54:00

The dynamic duo driving global growth

Molecule to Market: Inside the outsourcing space ·

2025/01/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with James Lovett, CEO and Mike Cohen, Executive Chairman at Myonex.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with James and Mike, covering: How a family-owned pharmacy became a major global clinical trial supplies business... two generations later Mike's decision to bring in a CEO and the challenge of letting go... before seeing the data

en

39:44

Biopharma Insights: Live from J.P. Morgan

Molecule to Market: Inside the outsourcing space ·

2025/01/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dean McAlister, Executive Vice President at Inizio Biotech.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dean, covering: The evolving dynamics within the life sciences sector and how they are shaping outsourcing strategies Key insights and trends from J.P. Morgan week, including challenges and opportunities for CROs and CDMOs The

en

54:23

The CEO making a global impact

Molecule to Market: Inside the outsourcing space ·

2025/01/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter DeYoung, CEO at Piramal Global Pharma.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: Why did Peter fall in love with the pharma sector? Why did he decide to leave McKinsey and jump into PE? The value of living and working in different places, and why you should jump at the chance if you ever get the opportunity to

en

45:07

2024 reflections and 2025 outlook in pharma services

Molecule to Market: Inside the outsourcing space ·

2025/01/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, a Managing Director and Partner in L.E.K. Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Reflections on 2024's market dynamics, shifting sponsor behavior, big pharma woes, biotech rebound and segment-specific impact The outlook for 2025 across discovery, development, clinical trials, and

en

45:48

From questions to answers: Celebrating 200 episodes

Molecule to Market: Inside the outsourcing space ·

2025/01/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal, Founder & Global President at ramarketing & Host of Molecule to Market.For this milestone episode, your host is Molecule to Market’s first guest from back in 2020, JoyL Silva, Customer Engagement Lead for the US Primary Care portfolio at Pfizer, who discusses the pharmaceutical and biotechnology supply chain with Raman Sehgal covering: Raman reflects on

en

240 results

Similar Podcasts

X Minus 1 - Old Time Radio Show

Inception Point Ai

Science, Spoken

WIRED

This Week in Space (Audio)

TWiT

DarshanTalks Podcast

Darshan Kulkarni

The Best of Coast to Coast AM

iHeartPodcasts and Coast to Coast AM